Health Care: Drugs

Allergan Inc (AGN: NYSE)

$184.82 -1.34 | -0.72%
10/22/14 - 12:01 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 6.30B 5.81B 5.42B 4.92B
Cost of Sales 669.70M 656.00M 614.50M 575.80M
Gross Operating Profit 5.63B 5.15B 4.80B 4.34B
Selling, General, and Administrative Expenses 2.52B 2.27B 2.25B 2.63B
Research & Development 1.04B 989.60M 902.80M 804.60M
Operating Income before D & A (EBITDA) 2.07B 1.89B 1.66B 912.20M
Depreciation & Amortization 242.80M 250.80M 261.80M 284.20M
Interest Income 6.80M 6.70M 6.90M 7.30M
Other Income - Net -10.30M -23.10M -500.00K -16.40M
Special Income / Charges -11.40M -22.30M -23.70M -369.10M
Total Income Before Interest Expenses (EBIT) 1.81B 1.60B 1.37B 249.50M
Interest Expense 75.00M 63.60M 71.80M 78.70M
Pre-Tax Income 1.73B 1.53B 1.30B 170.80M
Income Taxes 458.30M 430.80M 361.60M 165.90M
Minority Interest 3.60M 3.70M 3.60M 4.30M
Net Income From Continuing Operations 1.27B 1.10B 938.10M 4.90M
Net Income From Discontinued Operations -283.80M 0.00 0.00 0.00
Net Income From Total Operations 988.70M 1.10B 938.10M 4.90M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 985.10M 1.10B 934.50M 600.00K
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.29B 1.13B 966.40M 374.30M
Preferred Dividends
Net Income Available To Common 1.27B 1.10B 938.10M 4.90M
Basic EPS from Continuing Ops. 4.28 3.66 3.08 0.02
Basic EPS from Discontinued Ops. -0.96 0.00 0.00 0.00
Basic EPS from Total Operations 3.32 3.66 3.08 0.02
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.02 -0.01 -0.02
Basic EPS, Total 3.32 3.64 3.07 0.00
Basic Normalized Net Income/Share 4.34 3.75 3.17 1.23
EPS fr Continuing Ops. 4.20 3.59 3.02 0.02
EPS fr Discontinued Ops -0.96 0.00 0.00 0.00
EPS fr Total Ops. 3.24 3.59 3.02 0.02
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.02 -0.01 -0.01 -0.02
EPS, Total 3.26 3.58 3.01 0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
4.26 3.68 3.12 1.22
Dividends Paid per Share 0.20 0.20 0.20 0.20

Portfolios with AGN

Latest AGN Headlines from TheStreet

More Financial News for AGN

Press Releases for AGN

See All Press Releases

Partner Headlines for AGN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter